Changsatja, S., Kositamongkol, C. , Thamlikitkul, L. , Phisalprapa, P. and Komonpaisarn, T. 2025. COST-EFFECTIVENESS ANALYSIS OF ADJUVANT OSIMERTINIB IN RESECTED EGFR-MUTATED EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THAILAND. Proceedings of the International Conference on Public Health. 9, 1 (Jan. 2025), 45–67. DOI:https://doi.org/10.17501/24246735.2024.9105.